Switch to:
More From Other Websites
Can Novartis Tide Over the Alcon Crisis? Aug 26 2016
Novartis AG (NVS) Announces Positive Phase III Results For MS Drug Aug 26 2016
Novartis (NVS) Reports Positive Phase III Results on MS Drug Aug 26 2016
4:00 am Novartis reports phase III results of EXPAND study of BAF312 meets primary end point Aug 25 2016
Novartis announces positive phase III results showing efficacy of BAF312 in patients with secondary... Aug 25 2016
Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares Aug 24 2016
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics Aug 24 2016
Cyon Therapeutics Inc. acquires world-wide rights to an anti-PCSK9 antibody for use in Severe... Aug 23 2016
Novartis: First-Class Pharmaceuticals Aug 19 2016
5 Stocks That Beat The Market In A Crash Aug 18 2016
Turkey's investigation into drugmaker Novartis 'ongoing' -official Aug 17 2016
Turkey's investigation into drugmaker Novartis 'ongoing' -official Aug 17 2016
Turkey's investigation into drugmaker Novartis 'ongoing' - official Aug 17 2016
CSL to hike spending after profit fall Aug 17 2016
CSL to raise $US500m after mixed results Aug 16 2016
Novartis Needs to Stem the Bleeding From Gleevec Decline Aug 16 2016
Novartis Korea executives charged with bribing doctors Aug 13 2016
Novartis Korea executives charged with bribing doctors Aug 13 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK